(Q36262390)

13 August 2017

1 reference

title

Predictors of diabetic end-stage renal disease in Japan (English)

1 reference

13 August 2017

1 reference

Kunitoshi Iseki

1

1 reference

13 August 2017

1 October 2005

1 reference

13 August 2017

1 reference

13 August 2017

10 Suppl

1 reference

13 August 2017

S2-6

1 reference

Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Regional variations in the incidence of end-stage renal failure in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Current trend in prevalence of diabetes mellitus in Japan, 1964-1992.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

The growing volume of diabetes-related dialysis: a population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

CADASIL: a monogenic condition causing stroke and subcortical vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Age distribution and yearly changes in the incidence of ESRD in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Proteinuria and the risk of developing end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

The okinawa screening program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Influence of smoking and obesity on the development of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Systematic review: an evaluation of major commercial weight loss programs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Preventing end-stage renal disease: the potential impact of screening and intervention in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

The burden of kidney disease: improving global outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Glomerular number and size in relation to age, kidney weight, and body surface in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Nephron number in patients with primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Maps of end-stage renal disease and amounts of angiotensin-converting enzyme inhibitors prescribed in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Preventing microalbuminuria in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

Screening for proteinuria in US adults: a cost-effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

The rising tide of end-stage renal disease: what can be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1797.2005.00447.X

10.1111/J.1440-1797.2005.00447.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16174282